Unprecedented Rise in World Population and Changing Socio-Cultural Landscape Drives the Contraceptives Market, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Contraceptives markets. The global market for Contraceptives is forecast to exceed US$20 billion by 2018, buoyed by the increasing awareness about sexually transmitted diseases (STDs), ever-increasing global population, socio-cultural changes, Governmental support, and transforming demographic scenario, among others. The need for family planning and birth control are steering growth in the Contraceptives market. Emerging technological advances such as third-generation Oral Contraceptives and the Emergency Contraception Pill also bode well for the future growth of the market.

Contraceptives: A Global Strategic Business Report

Follow us on LinkedIn – Population growth in developing world coupled with HIV/AIDS scare in the West fueled a dramatic rise in the use of various methods of contraception ranging from universal oral contraceptives (OCs) and condoms to permanent procedures such as sterilization. The need for family planning and birth control are steering growth in the contraceptives market. Oral contraceptives and condoms win by a clear margin as the most preferred methods of contraception across the globe. Globally, the market is characterized by diverse regional trends in terms of usage, preferences, and availability of contraceptives. Oral contraceptives are hugely popular in Western and Central Africa, while use of injectable contraceptives is widespread in Eastern and Southern Africa and South East Asia. Governments play an important role in developing regions, where growing population and rise of incidences of STDs and AIDS are causes of national concern. Lack of disposable incomes and a conservative society add to the difficulties in marketing of contraceptives. Contraceptives are generally sold at subsidized rates or even distributed free-of-cost under various Social Marketing Programs conducted by local Government or by Non-Government Organizations (NGOs).

Over 220 million women have an unmet need for modern contraceptives. In the developing world, while the proportion of women using modern contraceptive methods has undergone little change over the years, the number of women with an unmet need for such contraceptives has remained the same owing to various factors. The turn of the 20th century witnessed a paradigm social transformation in the developing countries from large families to smaller ones. Increased usage of modern contraception methods, and rising participation by Governmental, non-Governmental agencies, private organizations, clinics and pharmacies to increase awareness through family planning programs have all fueled growth in modern contraceptives usage. The group which faces the greatest challenge among such women are those who are poor and with low education and who live in rural and semi-urban areas having low access to services.

Developed regions reflect a high degree of awareness and usage of contraceptives, although it differs from country to country. While the US is the largest consumer of oral contraceptives, usage of condoms is enormous in Japan. In developed countries, potential for growth still exists in the relatively mature markets in the form of effectively targeting under-tapped groups. Volume increases are the main concern compared to pricing. Premium pricing is restricted to developed world and urban areas of developing nations. Non-contraceptive indications for hormonal contraceptives and increasing preference for dual methods also have high inherent potential in terms of future growth. Furthermore, there exists significant demand potential for new formulations and delivery systems of contraceptive methods. Over the next few years, opportunities for growth from developing countries such as China, India and South Asia are projected to be much greater than the US and European markets.

Oral Contraceptives (OCs) are the most popular method of contraception in majority of the countries worldwide among both married and unmarried women. The OCs market is highly competitive and despite differences in classification of oral contraceptives, very little variations can be noticed in the currently available pills. Sales of branded oral contraceptives are therefore highly sensitive to promotional and advertising activities. Condoms represent one of the most preferred contraceptive methods used the world over and are primed to record a sturdy growth rate of 6.5% through 2018. Social marketing programs and public health campaigns promoting greater awareness, commercial advertising, expanded distribution channels, and use of condoms by unconventional users such as gays have resulted in an unprecedented increase in sales.

Developed markets of United States and Europe garner a substantial share of the global market for Contraceptives, as stated by the new research report. The market is driven by the growing need to avoid/postpone unwanted pregnancies, rising levels of education, sophistication, and need for pursuing career goals among young working women. About 60% of all pregnancies, particularly in developed nations such as the US are unplanned. Therefore, a keen interest in causes of unintended pregnancy and its control is one of the main criteria for Governments in the developed world. Majority of developing markets are plagued by issues of ever increasing population, alarming rise in sexually transmitted diseases and poor health and hygiene infrastructure. In the context, contraceptives with their tremendous potential to prevent undesired pregnancies and sexually transmitted diseases (STDs) hold bright growth prospects in the developing markets. Asia-Pacific, led by dynamically growing markets of India, China, Bangladesh, Pakistan and others, is set to expand at a robust CAGR of 8.6% over the analysis period.

Key players profiled in the report include Ansell Limited, Bayer HealthCare Pharmaceuticals, Church & Dwight Co Inc., Conceptus Inc., Condomi Health International GmbH, Female Health Company, Fuji Latex Co., Ltd., Johnson & Johnson, Merck & Co Inc., Okamoto Industries Inc., Reckitt Benckiser Group Plc, Teva Pharmaceutical Industries Limited, and many others.

The research report titled “Contraceptives: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive market overview, impact of recession, current market trends, key growth drivers, recent industry activity, and profiles of major/niche global market participants. The report provides annual sales estimates and projections for the years 2010 through 2018 in value terms (US$) for geographic markets including the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Key product segments analyzed include Oral Contraceptives, Condoms, Implants/Injections, and Others. The study also provides historic data for an insight into market evolution over the period 2004 through 2009.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website